Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check30 days agoChange DetectedA site-wide NIH banner about the transition from “Artificial Intelligence” to “Super Intelligence” appeared, and the site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check44 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check65 days agoChange DetectedThe history now shows a new revision entry for v3.7.0 as the latest update. The older revision label v3.6.6 has been removed from the visible history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.6.6 was added to the study's Record History. The previous revision v3.6.5 was removed.SummaryDifference0.1%

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.